{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:53:48Z","timestamp":1785542028560,"version":"3.56.0"},"reference-count":57,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Stereotactic radiosurgical capsulotomy (SRS-C) is an effective neurosurgical option for patients with treatment-resistant obsessive-compulsive disorder (TROCD). Unlike other procedures such as deep brain stimulation and radiofrequency ablation, the cost-effectiveness of SRS-C for TROCD has not been investigated. The authors herein report the first cost-effectiveness analysis of SRS-C for TROCD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Using a decision analytic model, the authors compared the cost-effectiveness of SRS-C to treatment as usual (TAU) for TROCD. Treatment response and complication rates were derived from a review of relevant clinical trials. Published algorithms were used to convert Yale-Brown Obsessive Compulsive Scale scores into utility scores reflecting improvements in quality of life. Costs were approached from the healthcare sector perspective and were drawn from Medicare reimbursement rates and available healthcare economics data. A Monte Carlo simulation and probabilistic sensitivity analysis were performed to estimate the incremental cost-effectiveness ratio.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>One hundred fifty-eight TROCD patients across 9 studies who had undergone SRS-C and had at least 36 months of follow-up were included in the model. Compared to TAU, SRS-C was more cost-effective, with an estimated incremental cost-effectiveness ratio of $28,960 per quality-adjusted life year (QALY) gained. Within the 3-year time horizon, net QALYs gained were greater in the SRS-C group than the TAU group by 0.27 (95% CI 0.2698\u20130.2702, p &lt; 0.0001). At willingness-to-pay thresholds of $50,000 and $100,000 per QALY, the Monte Carlo simulation revealed that SRS-C was more cost-effective than TAU in 83% and 100% of iterations, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Compared to TAU, SRS-C for TROCD is more cost-effective under a range of possible cost and effectiveness values.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2022.5.jns22474","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T13:07:25Z","timestamp":1659704845000},"page":"347-357","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder"],"prefix":"10.3171","volume":"138","author":[{"given":"Ricardo A.","family":"Najera","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Gregory","sequence":"additional","affiliation":[{"name":"Magellan Health, Frisco, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Shofty","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrish","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Gadot","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Youngerman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Columbia University Irving Medical Center, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Storch","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne K.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer A.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"11","key":"b1","series-title":"Validity. Arch Gen Psychiatry","first-page":"1012","article-title":"The Yale-Brown Obsessive Compulsive Scale. II","volume":"46","author":"Goodman WK","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA,  The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46(11):1012\u20131016.2510699"},{"issue":"5","key":"b2","series-title":"CNS Drugs","first-page":"367","article-title":"Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment","volume":"27","author":"Subramaniam M","year":"2013","unstructured":"Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27(5):367\u2013383.23580175"},{"issue":"1","key":"b3","series-title":"Mol Psychiatry","first-page":"53","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio AM","year":"2010","unstructured":"Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53\u201363.18725912"},{"issue":"2","key":"b4","series-title":"J Clin Psychiatry","first-page":"101","article-title":"A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder","volume":"60","author":"Pigott TA","year":"1999","unstructured":"Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry. 1999;60(2):101\u2013106.10084636"},{"key":"b5","series-title":"Clin Psychol Rev","first-page":"156","article-title":"Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014","volume":"40","author":"\u00d6st LG","year":"2015","unstructured":"\u00d6st LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015;40:156\u2013169.26117062"},{"issue":"1","key":"b6","series-title":"Int J Neuropsychopharmacol","first-page":"107","article-title":"Evidence-based pharmacotherapy of obsessive-compulsive disorder","volume":"8","author":"Fineberg NA","year":"2005","unstructured":"Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8(1):107\u2013129.15450126"},{"issue":"7","key":"b7","series-title":"Mol Psychiatry","first-page":"622","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch MH","year":"2006","unstructured":"Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11(7):622\u2013632.16585942"},{"issue":"2","key":"b8","series-title":"Int J Neuropsychopharmacol","first-page":"181","article-title":"Treatment non-response in OCD: methodological issues and operational definitions","volume":"5","author":"Pallanti S","year":"2002","unstructured":"Pallanti S, Hollander E, Bienstock C,  Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5(2):181\u2013191.12135542"},{"issue":"7","key":"b9","series-title":"J Clin Psychiatry","first-page":"949","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review","volume":"76","author":"Fontenelle LF","year":"2015","unstructured":"Fontenelle LF, Coutinho ES, Lins-Martins NM, Fitzgerald PB, Fujiwara H, Y\u00fccel M. Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review. J Clin Psychiatry. 2015;76(7):949\u2013957.25844888"},{"issue":"5","key":"b10","series-title":"Prim Care Companion CNS Disord","first-page":"18r02342","article-title":"A systematic review of the utility of electroconvulsive therapy in broadly defined obsessive-compulsive-related disorders","volume":"20","author":"Dos Santos-Ribeiro S","year":"2018","unstructured":"Dos Santos-Ribeiro S, de Salles Andrade JB, Quintas JN,  A systematic review of the utility of electroconvulsive therapy in broadly defined obsessive-compulsive-related disorders. Prim Care Companion CNS Disord. 2018;20(5):18r02342.30407758"},{"issue":"4","key":"b11","series-title":"J ECT","first-page":"262","article-title":"Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis","volume":"32","author":"Trevizol AP","year":"2016","unstructured":"Trevizol AP, Shiozawa P, Cook IA,  Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis. J ECT. 2016;32(4):262\u2013266.27327557"},{"issue":"7","key":"b12","series-title":"PLoS One","first-page":"e0133591","article-title":"Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response","volume":"10","author":"Alonso P","year":"2015","unstructured":"Alonso P, Cuadras D, Gabri\u00ebls L,  Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PLoS One. 2015;10(7):e0133591.26208305"},{"issue":"3","key":"b13","series-title":"Psychiatr Clin North Am","first-page":"393","article-title":"Neuromodulation in obsessive-compulsive disorder","volume":"37","author":"Bais M","year":"2014","unstructured":"Bais M, Figee M, Denys D. Neuromodulation in obsessive-compulsive disorder. Psychiatr Clin North Am. 2014;37(3):393\u2013413.25150569"},{"issue":"4","key":"b14","series-title":"J Neurol Neurosurg Psychiatry","first-page":"469","article-title":"Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study","volume":"90","author":"Kumar KK","year":"2019","unstructured":"Kumar KK, Appelboom G, Lamsam L,  Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study. J Neurol Neurosurg Psychiatry. 2019;90(4):469\u2013473.30679237"},{"issue":"6","key":"b15","series-title":"Neurosurgery","first-page":"1128","article-title":"Magnetic resonance imaging-guided laser thermal ventral capsulotomy for intractable obsessive-compulsive disorder","volume":"88","author":"McLaughlin NCR","year":"2021","unstructured":"McLaughlin NCR, Lauro PM, Patrick MT,  Magnetic resonance imaging-guided laser thermal ventral capsulotomy for intractable obsessive-compulsive disorder. Neurosurgery. 2021;88(6):1128\u20131135.33693795"},{"issue":"1","key":"b16","series-title":"J Neurosurg","first-page":"77","article-title":"Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies","volume":"124","author":"Brown LT","year":"2016","unstructured":"Brown LT, Mikell CB, Youngerman BE, Zhang Y, McKhann GM II, Sheth SA. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies. J Neurosurg. 2016;124(1):77\u201389.26252455"},{"issue":"2","key":"b17","series-title":"Mol Psychiatry","first-page":"218","article-title":"Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder","volume":"24","author":"Miguel EC","year":"2019","unstructured":"Miguel EC, Lopes AC, McLaughlin NCR,  Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder. Mol Psychiatry. 2019;24(2):218\u2013240.29743581"},{"issue":"9","key":"b18","series-title":"J Neurol Neurosurg Psychiatry","first-page":"797","article-title":"Stereotactic radiosurgery","volume":"46","author":"Leksell L","year":"1983","unstructured":"Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983;46(9):797\u2013803.6352865"},{"issue":"7","key":"b19","series-title":"Lakartidningen","first-page":"547","article-title":"F\u00f6rs\u00f6k med gammakapsulotomi vid \u00e5ngest- och tv\u00e5ngsneuroser","volume":"75","author":"Rylander G","year":"1978","unstructured":"Rylander G. F\u00f6rs\u00f6k med gammakapsulotomi vid \u00e5ngest- och tv\u00e5ngsneuroser. Lakartidningen. 1978;75(7):547\u2013549.342844"},{"issue":"3","key":"b20","series-title":"World Neurosurg","first-page":"S32.e1","article-title":"Radiosurgery for the treatment of psychiatric disorders: a review","volume":"80","author":"L\u00e9v\u00eaque M","year":"2013","unstructured":"L\u00e9v\u00eaque M, Carron R, R\u00e9gis J. Radiosurgery for the treatment of psychiatric disorders: a review. World Neurosurg. 2013;80(3):S32.e1\u2013S32.e9.23872618"},{"issue":"4","key":"b21","series-title":"Brain Stimul","first-page":"836","article-title":"Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder","volume":"10","author":"Ooms P","year":"2017","unstructured":"Ooms P, Blankers M, Figee M,  Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder. Brain Stimul. 2017;10(4):836\u2013842.28457837"},{"issue":"27","key":"b22","series-title":"Medicine (Baltimore)","first-page":"e7397","article-title":"The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder","volume":"96","author":"Moon W","year":"2017","unstructured":"Moon W, Kim SN, Park S, Paek SH, Kwon JS. The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder. Medicine (Baltimore). 2017;96(27):e7397.28682894"},{"key":"b23","series-title":"Front Neurosci","first-page":"66","article-title":"MR-guided focused ultrasound versus radiofrequency capsulotomy for treatment-refractory obsessive-compulsive disorder: a cost-effectiveness threshold analysis","volume":"13","author":"Kumar KK","year":"2019","unstructured":"Kumar KK, Bhati MT, Ravikumar VK, Ghanouni P, Stein SC, Halpern CH. MR-guided focused ultrasound versus radiofrequency capsulotomy for treatment-refractory obsessive-compulsive disorder: a cost-effectiveness threshold analysis. Front Neurosci. 2019;13:66.30792625"},{"issue":"5 Pt 1","key":"b24","series-title":"Health Serv Res","first-page":"1662","article-title":"Decision-analytic modeling to assist decision making in organizational innovation: the case of shared care in hearing aid provision","volume":"43","author":"Grutters JPC","year":"2008","unstructured":"Grutters JPC, Joore MA, van Der Horst F, Stokroos RJ, Anteunis LJC. Decision-analytic modeling to assist decision making in organizational innovation: the case of shared care in hearing aid provision. Health Serv Res. 2008;43(5 Pt 1):1662\u20131673.18522663"},{"issue":"7","key":"b25","series-title":"J Clin Psychiatry","first-page":"685","article-title":"Treatment response, symptom remission, and wellness in obsessive-compulsive disorder","volume":"74","author":"Farris SG","year":"2013","unstructured":"Farris SG, McLean CP, van Meter PE, Simpson HB, Foa EB. Treatment response, symptom remission, and wellness in obsessive-compulsive disorder. J Clin Psychiatry. 2013;74(7):685\u2013690.23945445"},{"issue":"12","key":"b26","series-title":"J Clin Psychiatry","first-page":"e1605","article-title":"Predicting course of illness in patients with severe obsessive-compulsive disorder","volume":"76","author":"Garnaat SL","year":"2015","unstructured":"Garnaat SL, Boisseau CL, Yip A,  Predicting course of illness in patients with severe obsessive-compulsive disorder. J Clin Psychiatry. 2015;76(12):e1605\u2013e1610.26717540"},{"issue":"15","key":"b27","series-title":"JAMA","first-page":"1253","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein MC","year":"1996","unstructured":"Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253\u20131258."},{"issue":"11","key":"b28","series-title":"Arch Gen Psychiatry","first-page":"1006","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman WK","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA,  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006\u20131011.2684084"},{"issue":"2","key":"b29","series-title":"J Clin Psychiatry","first-page":"17m11552","article-title":"Treatment-refractory obsessive-compulsive disorder in adults: a cost-effectiveness analysis of treatment strategies","volume":"79","author":"Gregory ST","year":"2018","unstructured":"Gregory ST, Kay B, Smith J,  Treatment-refractory obsessive-compulsive disorder in adults: a cost-effectiveness analysis of treatment strategies. J Clin Psychiatry. 2018;79(2):17m11552.29419948"},{"issue":"10","key":"b30","series-title":"Pharmacoeconomics","first-page":"1135","article-title":"Perspective and costing in cost-effectiveness analysis, 1974\u20132018","volume":"38","author":"Kim DD","year":"2020","unstructured":"Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and costing in cost-effectiveness analysis, 1974\u20132018. Pharmacoeconomics. 2020;38(10):1135\u20131145.32696192"},{"key":"b31","article-title":"CMS physician fee schedule. Centers for Medicare & Medicaid Services","unstructured":"CMS physician fee schedule. Centers for Medicare & Medicaid Services. Accessed June 7, 2022.https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched"},{"issue":"1","key":"b32","series-title":"J Clin Neurosci","first-page":"184","article-title":"A cost comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology","volume":"22","author":"Caruso JP","year":"2015","unstructured":"Caruso JP, Moosa S, Fezeu F, Ramesh A, Sheehan JP. A cost comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology. J Clin Neurosci. 2015;22(1):184\u2013188.25444994"},{"key":"b33","series-title":"World Neurosurgery","first-page":"207","article-title":"Comparing microvascular decompression with Gamma Knife radiosurgery for trigeminal neuralgia. a cost-effectiveness analysis","volume":"125","author":"Gandhoke GS","year":"2019","unstructured":"Gandhoke GS, Smith KJ, Niranjan A, Sekula RF, Lunsford LD. Comparing microvascular decompression with Gamma Knife radiosurgery for trigeminal neuralgia. a cost-effectiveness analysis. World Neurosurgery. 2019;125:207\u2013216.30660885"},{"issue":"1","key":"b34","series-title":"Mol Psychiatry","first-page":"64","article-title":"Deep brain stimulation of the ventral internal capsule\/ventral striatum for obsessive-compulsive disorder: worldwide experience","volume":"15","author":"Greenberg BD","year":"2010","unstructured":"Greenberg BD, Gabriels LA, Malone DA Jr,  Deep brain stimulation of the ventral internal capsule\/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15(1):64\u201379.18490925"},{"issue":"2","key":"b35","series-title":"Clin Neurol Neurosurg","first-page":"137","article-title":"Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year","volume":"112","author":"Huff W","year":"2010","unstructured":"Huff W, Lenartz D, Schormann M,  Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year. Clin Neurol Neurosurg. 2010;112(2):137\u2013143.20006424"},{"issue":"2","key":"b36","series-title":"Brain Stimul","first-page":"344","article-title":"Inferior thalamic peduncle deep brain stimulation for treatment-refractory obsessive-compulsive disorder: a phase 1 pilot trial","volume":"12","author":"Lee DJ","year":"2019","unstructured":"Lee DJ, Dallapiazza RF, De Vloo P,  Inferior thalamic peduncle deep brain stimulation for treatment-refractory obsessive-compulsive disorder: a phase 1 pilot trial. Brain Stimul. 2019;12(2):344\u2013352.30514614"},{"key":"b37","article-title":"Cost-Effectiveness in Health and Medicine","author":"Gold MR","year":"1996","unstructured":"Gold MR. Cost-Effectiveness in Health and Medicine. Oxford University Press;1996."},{"issue":"71","key":"b38","series-title":"BMJ","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM,  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71.33782057"},{"issue":"8","key":"b39","series-title":"Arch Gen Psychiatry","first-page":"914","article-title":"Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients","volume":"65","author":"R\u00fcck C","year":"2008","unstructured":"R\u00fcck C, Karlsson A, Steele JD,  Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients. Arch Gen Psychiatry. 2008;65(8):914\u2013921.18678796"},{"issue":"4","key":"b40","series-title":"J Neuropsychiatry Clin Neurosci","first-page":"381","article-title":"Treatment of resistant obsessive-compulsive disorder with ventral capsular\/ventral striatal gamma capsulotomy: a pilot prospective study","volume":"21","author":"Lopes AC","year":"2009","unstructured":"Lopes AC, Greenberg BD, Nor\u00e9n G,  Treatment of resistant obsessive-compulsive disorder with ventral capsular\/ventral striatal gamma capsulotomy: a pilot prospective study. J Neuropsychiatry Clin Neurosci. 2009;21(4):381\u2013392.19996246"},{"issue":"1","key":"b41","series-title":"Neurosurgery","first-page":"28","article-title":"Results following gamma knife radiosurgical anterior capsulotomies for obsessive compulsive disorder","volume":"68","author":"Kondziolka D","year":"2011","unstructured":"Kondziolka D, Flickinger JC, Hudak R. Results following gamma knife radiosurgical anterior capsulotomies for obsessive compulsive disorder. Neurosurgery. 2011;68(1):28\u201333.21150752"},{"issue":"5","key":"b42","series-title":"J Neurosurg","first-page":"1112","article-title":"Gamma Knife surgery anterior capsulotomy for severe and refractory obsessive-compulsive disorder","volume":"119","author":"Sheehan JP","year":"2013","unstructured":"Sheehan JP, Patterson G, Schlesinger D, Xu Z. Gamma Knife surgery anterior capsulotomy for severe and refractory obsessive-compulsive disorder. J Neurosurg. 2013;119(5):1112\u20131118.23829816"},{"issue":"9","key":"b43","series-title":"JAMA Psychiatry","first-page":"1066","article-title":"Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial","volume":"71","author":"Lopes AC","year":"2014","unstructured":"Lopes AC, Greenberg BD, Canteras MM,  Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):1066\u20131076.25054836"},{"issue":"5","key":"b44","series-title":"Biol Psychiatry","first-page":"355","article-title":"Gamma ventral capsulotomy in intractable obsessive-compulsive disorder","volume":"84","author":"Rasmussen SA","year":"2018","unstructured":"Rasmussen SA, Noren G, Greenberg BD,  Gamma ventral capsulotomy in intractable obsessive-compulsive disorder. Biol Psychiatry. 2018;84(5):355\u2013364.29361268"},{"issue":"2","key":"b45","series-title":"J Neurosurg","first-page":"376","article-title":"Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients","volume":"131","author":"Spatola G","year":"2018","unstructured":"Spatola G, Martinez-Alvarez R, Mart\u00ednez-Moreno N,  Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients. J Neurosurg. 2018;131(2):376\u2013383."},{"issue":"6","key":"b46","series-title":"Neurosurgery","first-page":"808","article-title":"An International Radiosurgery Research Foundation multicenter retrospective study of gamma ventral capsulotomy for obsessive compulsive disorder","volume":"85","author":"Gupta A","year":"2019","unstructured":"Gupta A, Shepard MJ, Xu Z,  An International Radiosurgery Research Foundation multicenter retrospective study of gamma ventral capsulotomy for obsessive compulsive disorder. Neurosurgery. 2019;85(6):808\u2013816.30476294"},{"key":"b47","series-title":"World Neurosurg","first-page":"e941","article-title":"Efficacy and safety of gamma ventral capsulotomy for treatment-resistant obsessive-compulsive disorder: a single-center experience","volume":"141","author":"Peker S","year":"2020","unstructured":"Peker S, Samanci MY, Yilmaz M, Sengoz M, Ulku N, Ogel K. Efficacy and safety of gamma ventral capsulotomy for treatment-resistant obsessive-compulsive disorder: a single-center experience. World Neurosurg. 2020;141:e941\u2013e952.32565377"},{"issue":"11","key":"b48","series-title":"Cancer Med","first-page":"4026","article-title":"Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study","volume":"9","author":"Gatterbauer B","year":"2020","unstructured":"Gatterbauer B, Hirschmann D, Eberherr N,  Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study. Cancer Med. 2020;9(11):4026\u20134036."},{"issue":"8","key":"b49","series-title":"Mov Disord","first-page":"1165","article-title":"Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor","volume":"32","author":"Ravikumar VK","year":"2017","unstructured":"Ravikumar VK, Parker JJ, Hornbeck TS,  Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor. Mov Disord. 2017;32(8):1165\u20131173.28370272"},{"key":"b50","series-title":"Defining the Value of Medical Interventions: Normative and Empirical Challenges","article-title":"The cost-effectiveness of what in health and care?","author":"Mitchell PM","year":"2021","unstructured":"Mitchell PM. The cost-effectiveness of what in health and care?. In: Schildmann J, Buch C, Zerth J, eds.Defining the Value of Medical Interventions: Normative and Empirical Challenges. Kohlhammer Verlag;2021."},{"key":"b51","series-title":"Front Surg","first-page":"642503","article-title":"The decline of deep brain stimulation for obsessive-compulsive disorder following FDA humanitarian device exemption approval","volume":"8","author":"Pinckard-Dover H","year":"2021","unstructured":"Pinckard-Dover H, Ward H, Foote KD. The decline of deep brain stimulation for obsessive-compulsive disorder following FDA humanitarian device exemption approval. Front Surg. 2021;8:642503.33777998"},{"issue":"5","key":"b52","series-title":"Neurosurgery","first-page":"871","article-title":"Cost-effectiveness research in neurosurgery: we can and we must","volume":"83","author":"Stein SC","year":"2018","unstructured":"Stein SC. Cost-effectiveness research in neurosurgery: we can and we must. Neurosurgery. 2018;83(5):871\u2013878.29315414"},{"issue":"3","key":"b53","series-title":"J Clin Psychiatry","first-page":"233","article-title":"Five-year course of obsessive-compulsive disorder: predictors of remission and relapse","volume":"74","author":"Eisen JL","year":"2013","unstructured":"Eisen JL, Sibrava NJ, Boisseau CL,  Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. J Clin Psychiatry. 2013;74(3):233\u2013239.23561228"},{"key":"b54","first-page":"65","article-title":"A clinical staging model for obsessive-compulsive disorder: is it ready for prime time? EClinicalMedicine","volume":"7","author":"Fontenelle LF","year":"2019","unstructured":"Fontenelle LF, Y\u00fccel M. A clinical staging model for obsessive-compulsive disorder: is it ready for prime time? EClinicalMedicine. 2019;7:65\u201372.31193644"},{"issue":"4","key":"b55","series-title":"J Neurosurg","first-page":"937","article-title":"Delayed cyst formation after stereotactic radiosurgery for brain arteriovenous malformations","volume":"129","author":"Pomeraniec IJ","year":"2018","unstructured":"Pomeraniec IJ, Ding D, Starke RM,  Delayed cyst formation after stereotactic radiosurgery for brain arteriovenous malformations. J Neurosurg. 2018;129(4):937\u2013946.29192860"},{"issue":"8","key":"b56","series-title":"Neuropsychopharmacology","first-page":"1837","article-title":"Visuospatial memory improvement after gamma ventral capsulotomy in treatment refractory obsessive-compulsive disorder patients","volume":"40","author":"Batistuzzo MC","year":"2015","unstructured":"Batistuzzo MC, Hoexter MQ, Taub A,  Visuospatial memory improvement after gamma ventral capsulotomy in treatment refractory obsessive-compulsive disorder patients. Neuropsychopharmacology. 2015;40(8):1837\u20131845.25645373"},{"key":"b57","series-title":"U.S. Census Bureau","article-title":"Health Insurance Coverage in the United States: 2020","author":"Keisler-Starkey K","year":"2021","unstructured":"Keisler-Starkey K, Bunch LN. Health Insurance Coverage in the United States: 2020. U.S. Census Bureau; 2021.Accessed June 7, 2022.https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2021\/demo\/p60-274.pdf"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/2\/article-p347.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/2\/article-p347.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/2\/article-p347.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:11:31Z","timestamp":1732194691000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/2\/article-p347.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":57,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2022.5.jns22474","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}